MacQS: A Novel Synthetic Immune Cell Therapy for Biofilm Eradication in Cystic Fibrosis

Ingenious+Health and well-being2025ONRegional Winner

Submitted by: Krish Mendapara

Region: Ontario

students in lab

Project description

MacQS is a novel synthetic immune cell therapy designed to target Pseudomonas aeruginosa – a leading cause of Cystic Fibrosis. Current. MacQS disrupts bacterial persistence by offering lab-developed and research-driven therapy.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.